KUALA LUMPUR: Phamaniaga Bhd has the capacity to manufacture two million doses of COVID-19 vaccine developed by Sinovac Life Sciences Co Ltd per month beginning March this year.
Group managing director Datuk Zulkarnain Md Eusope said the vaccine would be the first to be manufactured in Malaysia at the small volume injectable high-tech plant owned by Pharmaniaga‘s wholly-owned subsidiary, Pharmaniaga LifeSciences Sdn Bhd, in Puchong.
He said the group would invest RM3 million to retrofit the plant to enable the production of the vaccine.
“We are very confident in carrying out the task successfully because our technical experts have been working on setting up a halal vaccine plant in Malaysia since 2017.
“When the COVID-19 spread around the world early last year, we immediately chanelled our team to work with our global partners, including Sinovac on the fill and finish manufacturing activity and technology transfer to speed up the